Literature DB >> 8270131

Insulin receptor tyrosine kinase activity is reduced in monocytes from non-obese normoglycaemic insulin-resistant subjects.

L Frittitta1, G Grasso, M E Munguira, R Vigneri, V Trischitta.   

Abstract

Insulin sensitivity has been quantified by i.v. insulin tolerance test (0.1 U/kg of body weight) in 18 (11 male/7 female) non-obese (body mass index range 19-25 kg/m2) normoglycaemic subjects. We then compared the tyrosine kinase activity and internalization of insulin receptor in monocytes from the six most insulin-sensitive (group 1) and the six most insulin-resistant (group 3) subjects. Tyrosine kinase activity was measured on immunopurified receptors using 32P-ATP and poly-glutamic acid 4: tyrosine 1, sodium salt (poly-glu-tyr 4:1). Insulin internalization was studied by incubating cells with 1 nmol/l 125I-insulin and measuring total cell-bound and intracellular 125I-insulin by an acid dissociation procedure. Basal (in the absence of insulin) receptor kinase activity was similar in both groups. Maximal (in the presence of 100 nmol/l insulin) kinase activity was 41% lower in group 3 (13.8 +/- 3.6 fmoles 32P-ATP incorporated vs 23.3 +/- 4.0, p = 0.1). Delta increment of receptor kinase activity after insulin stimulation (calculated by subtracting basal from maximal activity) was significantly (p < 0.05) reduced in group 3 (21.3 +/- 3.8 vs 11.1 +/- 2.1) and significantly (p < 0.05) correlated to the in vivo insulin sensitivity. Both total cell-bound (0.70 +/- 0.09% of total radioactivity added vs 0.83 +/- 0.15) and intracellular (0.39 +/- 0.05 vs 0.44 +/- 0.09) 125I-insulin were similar in the two groups. These data suggest that in non-obese, normoglycaemic subjects a defective insulin receptor tyrosine kinase activity may contribute to the development of insulin resistance.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8270131     DOI: 10.1007/bf00401061

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  19 in total

Review 1.  Mutations in the insulin receptor gene.

Authors:  S I Taylor; A Cama; D Accili; F Barbetti; M J Quon; M de la Luz Sierra; Y Suzuki; E Koller; R Levy-Toledano; E Wertheimer
Journal:  Endocr Rev       Date:  1992-08       Impact factor: 19.871

2.  Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  P Arner; T Pollare; H Lithell; J N Livingston
Journal:  Diabetologia       Date:  1987-06       Impact factor: 10.122

3.  Defect in phosphorylation of insulin receptors in cells from an insulin-resistant patient with normal insulin binding.

Authors:  G Grunberger; Y Zick; P Gorden
Journal:  Science       Date:  1984-03-02       Impact factor: 47.728

4.  Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes.

Authors:  J F Caro; M K Sinha; S M Raju; O Ittoop; W J Pories; E G Flickinger; D Meelheim; G L Dohm
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

5.  Insulin-mimetic anti-insulin receptor monoclonal antibodies stimulate receptor kinase activity in intact cells.

Authors:  G Steele-Perkins; R A Roth
Journal:  J Biol Chem       Date:  1990-06-05       Impact factor: 5.157

6.  Defective insulin receptor function in down-regulated HepG2 cells.

Authors:  J F Williams; J M Olefsky
Journal:  Endocrinology       Date:  1990-10       Impact factor: 4.736

7.  Insulin-stimulated glucose transport in circulating mononuclear cells from nondiabetic and IDDM subjects.

Authors:  D Daneman; B Zinman; M E Elliott; P J Bilan; A Klip
Journal:  Diabetes       Date:  1992-02       Impact factor: 9.461

8.  Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies.

Authors:  E Bonora; P Moghetti; C Zancanaro; M Cigolini; M Querena; V Cacciatori; A Corgnati; M Muggeo
Journal:  J Clin Endocrinol Metab       Date:  1989-02       Impact factor: 5.958

9.  Defects in insulin-receptor internalization and processing in monocytes of obese subjects and obese NIDDM patients.

Authors:  V Trischitta; A Brunetti; A Chiavetta; L Benzi; V Papa; R Vigneri
Journal:  Diabetes       Date:  1989-12       Impact factor: 9.461

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more
  7 in total

1.  PC-1 content in skeletal muscle of non-obese, non-diabetic subjects: relationship to insulin receptor tyrosine kinase and whole body insulin sensitivity.

Authors:  L Frittitta; J Youngren; R Vigneri; B A Maddux; V Trischitta; I D Goldfine
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

Review 2.  Role of insulin action in the pathogenesis of diabetic complications.

Authors:  Kyoichiro Tsuchiya
Journal:  Diabetol Int       Date:  2022-09-07

3.  Tauroursodeoxycholic acid attenuates lipid accumulation in endoplasmic reticulum-stressed macrophages.

Authors:  Yinan Hua; Machender R Kandadi; Meijun Zhu; Jun Ren; Nair Sreejayan
Journal:  J Cardiovasc Pharmacol       Date:  2010-01       Impact factor: 3.105

4.  Increased CD36 protein as a response to defective insulin signaling in macrophages.

Authors:  Chien-Ping Liang; Seongah Han; Haruka Okamoto; Ronald Carnemolla; Ira Tabas; Domenico Accili; Alan R Tall
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

Review 5.  The link between insulin resistance and hypertension. Effects of antihypertensive and antihyperlipidaemic drugs on insulin sensitivity.

Authors:  T Baba; S Neugebauer
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

6.  Insulin receptor tyrosine-kinase activity is altered in both muscle and adipose tissue from non-obese normoglycaemic insulin-resistant subjects.

Authors:  G Grasso; L Frittitta; M Anello; P Russo; G Sesti; V Trischitta
Journal:  Diabetologia       Date:  1995-01       Impact factor: 10.122

7.  Loss of Pdk1-Foxo1 signaling in myeloid cells predisposes to adipose tissue inflammation and insulin resistance.

Authors:  Yoshinaga Kawano; Jun Nakae; Nobuyuki Watanabe; Shiho Fujisaka; Kristy Iskandar; Risa Sekioka; Yoshitake Hayashi; Kazuyuki Tobe; Masato Kasuga; Tetsuo Noda; Akihiko Yoshimura; Masafumi Onodera; Hiroshi Itoh
Journal:  Diabetes       Date:  2012-05-14       Impact factor: 9.461

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.